4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-060116
Chief Operating Officer sold 3,125 shares at an average $33.16 ($103,630)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2021-10-07 | Sale | −1,324 | $32.47 | $42,990 | 53,655 | D: show line 1 in the form |
| ADAMS R MARK Chief Operating Officer | 2021-10-08 | Sale | −1,801 | $33.67 | $60,640 | 51,854 | D: show line 2 in the form |
| Open-market sales · 3,125 sh · avg $33.16 · $103,630 | |||||||
Loading xslF345X03/doc4.xml…